Cannabinoid Hyperemesis Syndrome Treated With Fosaprepitant: A Case Report
Abstract Cannabinoid hyperemesis syndrome (CHS) is a condition in which users of marijuana experience symptoms of nausea and vomiting. Due…
antiemetics
The Pharmacological and Clinical Roles of Antiemetics: A Narrative Review
Abstract Emesis (e.g., vomiting and nausea) can be a nebulous condition to treat, as it has many and highly varied…
Mitigating the Risk of QTc Prolongation When Using Haloperidol for Acute Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents and Young Adults
Abstract Background/Objectives: Cannabinoid Hyperemesis Syndrome (CHS), associated with long-term cannabinoid use, has been increasingly observed in emergency room visits as…
NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK
Abstract Background: The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and…
Recent advances in pharmacotherapy of chemotherapy-induced nausea and vomiting
Abstract Nausea and vomiting remain among the most feared side effects of chemotherapy for cancer patients. Significant progress has been…
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting
Abstract Chemotherapy-induced nausea and vomiting (CINV) is a complex pathophysiological condition and consists of two phases. The conventional CINV neurotransmitter…